Neogen Corp (NEOG)
12.34
-0.10
(-0.84%)
USD |
NASDAQ |
May 10, 16:00
12.34
0.00 (0.00%)
After-Hours: 20:00
Neogen Debt to Equity Ratio: 0.2821 for Feb. 29, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.2821 |
| November 30, 2023 | 0.2818 |
| August 31, 2023 | 0.2817 |
| May 31, 2023 | 0.2825 |
| February 28, 2023 | 0.2831 |
| November 30, 2022 | 0.2975 |
| August 31, 2022 | 0.00 |
| May 31, 2022 | 0.00 |
| February 28, 2022 | 0.00 |
| November 30, 2021 | 0.00 |
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.00 |
| November 30, 2020 | 0.00 |
| August 31, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| February 29, 2020 | 0.00 |
| November 30, 2019 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| Date | Value |
|---|---|
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 0.00 |
| February 28, 2013 | 0.00 |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.00 |
| May 31, 2012 | 0.00 |
| February 29, 2012 | 0.00 |
| November 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
May 2019
0.2975
Maximum
Nov 2022
0.0854
Average
--
Median
May 2019
Debt to Equity Ratio Benchmarks
| Moderna Inc | 0.00 |
| Regeneron Pharmaceuticals Inc | 0.0735 |
| Syros Pharmaceuticals Inc | 2.474 |
| Disc Medicine Inc | -- |
| Amylyx Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.582B |
| Total Liabilities (Quarterly) | 1.436B |
| Shareholders Equity (Quarterly) | 3.146B |
| Current Ratio | 3.817 |
| Net Debt Paydown Yield | 0.20% |